<DOC>
	<DOC>NCT01470118</DOC>
	<brief_summary>This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.</brief_summary>
	<brief_title>A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Alcaftadine</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>History of eye allergies within the past 24 months Willing to not wear contact lenses at least 72 hours prior to the study start and during the study period Current eye infection Eye surgery within 3 months or vision correction surgery within 6 months Any planned surgery during the study or 30 days after the study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>